Scott Wolchko | President and CEO |
Dr. Dan Shoemaker | Chief Scientific Officer |
Ted Tenthoff | Piper Jaffary |
Kripa Devarakonda | Citi |
Yanan Zhu | Wells Fargo |
Biren Amin | Jefferies |
Matt Biegler | Oppenheimer |
Reni Benjamin | Raymond James |
Welcome to the Fate Therapeutics Fourth Quarter 2018 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the Investors & Media section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.